Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Simpson-Golabi-Behmel syndrome in which the cause of the disease is a mutation in the GPC3 gene.
Features include always present findings: Anal atresia, Trigonocephaly, Hypertrichosis, and Downslanted palpebral fissures and others; and very common findings: Broad forehead, Coarse facial features, and Macroglossia. 99 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 7 | Submucous cleft lip, Narrow palate, Coarse facial features |
Arms and legs | 7 | Postaxial hand polydactyly, Broad toe, Short foot |
Digestive system | 5 | Hepatoblastoma, Enlarged liver (hepatomegaly), Enlarged spleen (splenomegaly) |
Heart and blood vessels | 5 | Right ventricular hypertrophy, Arrhythmia, Ventricular septal defect |
Bones and joints | 4 | Six lumbar vertebrae, Sideways curvature of the spine (scoliosis), Accelerated skeletal maturation |
Kidneys and urinary system | 4 | Nephroblastoma, Renal cyst, Enlarged kidney |
Brain and nerves | 3 | Hydrocephalus, Delayed speech and language development, Depressed nasal bridge |
Lungs and breathing | 3 | Neonatal respiratory distress, Abnormal lung lobation, Total anomalous pulmonary venous return |
Skin | 2 | Short nail, Preauricular skin tag |
Pregnancy and birth | 2 | Neonatal respiratory distress, Congenital diaphragmatic hernia |
Muscles | 2 | Low muscle tone (hypotonia), Facial hypotonia |
Ears | 1 | Hearing loss (hearing impairment) |
Growth and development | 1 | Tall stature |
Blood and immune system | 1 | Enlarged spleen (splenomegaly) |
Age of onset: before birth, at birth.
Males and females can present similarly with Simpson-Golabi-Behmel syndrome type 1 (SGBS1). However, there is skewing of males to females in a 9:1 ratio. Individuals of both sexes present with overgrowth, characteristic facial features, skeletal abnormalities, and genitourinary dysfunction. Males often present with cryptorchidism. Females are less likely to present with significant manifestations of SGBS1, potentially due to skewed X-chromosome inactivation. There have not been extensive studies of sex differences in SGBS1 due to the small number of females reported to date and mildly affected or unaffected female carriers who do not present until they have an affected son. Affected Males SGBS1 is characterized by pre- and postnatal overgrowth, distinctive facies, and variable visceral, skeletal, and neurodevelopmental abnormalities. To date, more than 180 individuals have been identified with a pathogenic variant in GPC3 . The following description of the phenotypic features associated with this condition is based on these reports. Table 2. Simpson-Golabi-Behmel Syndrome Type 1: Frequency of Select Features
System | Feature | % of Persons w/Feature |
|---|---|---|
Overgrowth |
GPC3 encodes glypican 3 (580 aa). Cell surface proteoglycan. Highest expression in Lung (201.3 TPM) and Adipose Subcutaneous (146.7 TPM).
Simpson-Golabi-Behmel syndrome type 1 is associated with mutations in the GPC3 gene on chromosome X.
GPC3 is classified as a druggable target (Cell Surface, Clinically Actionable, and Druggable Genome categories) with score 10.4.
There are no known clinically relevant genotype-phenotype correlations for SGBS1 to date.
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
All males reported with a GPC3 pathogenic variant have clinical findings of SGBS1. Penetrance in heterozygous females is unknown, but unaffected or mildly affected females have been reported .
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
For the purposes of this GeneReview, the terms "male" and "female" are narrowly defined as the individual's biological sex at birth as it determines clinical care . Consensus clinical diagnostic criteria for Simpson-Golabi-Behmel syndrome type 1 (SGBS1) have not been established.
SGBS1 should be suspected in probands with the following clinical findings and family history.
Clinical findings
• Linear somatic overgrowth
• Macrocephaly
• Characteristic facial features
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
Table 3.
Disorders to Consider in the Differential Diagnosis of Simpson-Golabi-Behmel Syndrome Type 1
Gene(s) | Disorder | MOI | Clinical Features of Disorder
Overlapping w/SGBS1 | Distinguishing from SGBS1
See footnote 1. | Beckwith-Wiedemann syndrome (BWS) | See footnote 1. | • Macrosomia
Macroglossia
Ear anomalies
Diastasis recti
Hypoglycemia
Genitourinary malformations
incidence of tumors
| • Appreciably different facial features (midface flattening in BWS; broader forehead in SGBS1)
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
Genetic testing for GPC3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Simpson-Golabi-Behmel syndrome type 1 has been reported in the published literature.
No approved treatments are currently available for Simpson-Golabi-Behmel syndrome type 1. The disease remains an area of unmet medical need.
No clinical practice guidelines for Simpson-Golabi-Behmel syndrome type 1 (SGBS1) have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with SGBS1, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
Simpson-Golabi-Behmel Syndrome Type 1: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Assess for macroglossia orofacial clefting. | Referral to craniofacial team incl feeding specialists
Eyes | Ophthalmologic exam |
| Audiologic eval |
| Consider chest radiograph, EKG, echocardiogram. | To evaluate for structural heart defects conduction abnormalities
| Assess for upper-airway sufficiency signs/symptoms of sleep apnea; consider formal sleep study. | Particularly in those w/hypotonia macroglossia
| Exam for hypospadias undescended testes in males; renal ultrasound to assess for renal anomalies | Referral to urologist as needed
| Abdominal/pelvic ultrasound to initiate tumor screening | Further studies (e.g., MRI) may be indicated if findings are suspicious for a tumor.
Measurement of serum AFP | As a baseline screen for hepatoblastoma
| Clinical eval for scoliosis | Particula...
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
View trials for Simpson-Golabi-Behmel syndrome type 1
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. Simpson-Golabi-Behmel Syndrome Type 1: Recommended Surveillance for Males
System/Manifestation | Evaluation | Frequency/Comment |
|---|---|---|
Eyes | Ophthalmologic eval | Annually in childhood or as indicated Hearing |
Respiratory | Sleep study | If history of sleep disturbance |
Renal | Routine monitoring of kidney function | If renal anomalies present |
Musculoskeletal | Eval for scoliosis | At least annually or during periods of rapid growth |
Endocrine | Monitor serum glucose levels for hypoglycemia secondary to risk for hyperinsulinemia. | In neonatal period |
Neurodevelopment | Monitor for developmental progress. | At each clinic visit |
Cancer predisposition | Tumor screening for Wilms tumor hepatoblastoma | Abdominal ultrasound serum AFP level every 3 mos from time of diagnosis until age 3 yrs Tumor screening for neuroblastoma gonadoblastoma |
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"
Phenotype severity distribution: 22 always present features, 3 very common features, 16 common features.
No clinical trials have been registered for Simpson-Golabi-Behmel syndrome type 1.
28 publications have been identified in PubMed for Simpson-Golabi-Behmel syndrome type 1. Research spans Basic Science / Preclinical (48%), Case Report / Case Series (22%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 13 | 48% |
Patient case studies | 6 | 22% |
Research summaries | 5 | 19% |
Other research | 1 | 4% |
Testing and diagnosis research | 1 | 4% |
Disease patterns and progression | 1 | 4% |
Rishabh RK (2026). [PMID: 42220602](https://pubmed.ncbi.nlm.nih.gov/42220602/). *JCEM Case Rep*. [Case Report / Case Series]
Li Q (2026). [PMID: 41495449](https://pubmed.ncbi.nlm.nih.gov/41495449/). *Int J Obes (Lond)*. [Basic Science / Preclinical]
Moss T (2026). [PMID: 41332312](https://pubmed.ncbi.nlm.nih.gov/41332312/). *Am J Med Genet A*. [Case Report / Case Series]
Zhao T (2026). [PMID: 41122961](https://pubmed.ncbi.nlm.nih.gov/41122961/). *Am J Med Genet A*. [Case Report / Case Series]
Colitti M (2026). [PMID: 41880863](https://pubmed.ncbi.nlm.nih.gov/41880863/). *Tissue Cell*. [Basic Science / Preclinical]
Dignam JP (2026). [PMID: 41320177](https://pubmed.ncbi.nlm.nih.gov/41320177/). *Br J Pharmacol*. [Case Report / Case Series]
Xu X (2026). [PMID: 41546782](https://pubmed.ncbi.nlm.nih.gov/41546782/). *J Mol Histol*. [Basic Science / Preclinical]
Matilainen J (2026). [PMID: 42243441](https://pubmed.ncbi.nlm.nih.gov/42243441/). *Inflamm Res*. [Basic Science / Preclinical]
Payet T (2025). [PMID: 39887543](https://pubmed.ncbi.nlm.nih.gov/39887543/). *Biofactors*. [Epidemiology / Natural History]
Piao Q (2025). [PMID: 40422229](https://pubmed.ncbi.nlm.nih.gov/40422229/). *Cells*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 3:06 PM UTC
Online Mendelian Inheritance in Man
Common questions about Simpson-Golabi-Behmel syndrome type 1
Overgrowth (linear growth ≥2 SD above mean for age sex)
89% |
Facial features | Macroglossia | 81% Macrostomia |
Cardiac | Congenital heart disease | 46% |
Genitourinary | Renal dysplasia, nephromegaly, duplicated renal system | 58% Cryptorchidism, hypospadias in males |
Musculoskeletal | Scoliosis, hand foot anomalies (e.g., brachydactyly, cutaneous syndactyly, polydactyly) | 59% |
Neurodevelopmental | Intellectual disability | 58% |
Neoplasia | Hepatoblastoma Wilms tumor (most common) | 10% |
Other features | Supernumerary nipples | 59% Diastasis recti, umbilical hernia |
Source: GeneReviews — "Simpson-Golabi-Behmel Syndrome Type 1"